# Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia

> **NCT03476330** · PHASE2 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 48 (actual)

## Conditions studied

- Fanconi Anemia
- Squamous Cell Carcinoma

## Interventions

- **DRUG:** Quercetin (dietary supplement)

## Key facts

- **NCT ID:** NCT03476330
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-08
- **Primary completion:** 2025-03-06
- **Final completion:** 2026-01-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03476330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03476330, "Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03476330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*